In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner

Journal of Neuroscience Methods

Volumn 76, Issue 1, 1997, Pages 45-51

  Hume, Susan P ^a   Brown, David J ^a   Ashworth, Sharon ^a   Hirani, Ella ^a   Luthra, Sajinder K ^a   Lammertsma, Adriaan A ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CFT; Dopamine transporter; Positron emission tomography; Rat; RTI 121

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARRIER PROTEIN; COCAINE DERIVATIVE; DOPAMINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY;

ANIMALS; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEOSTRIATUM; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030869387     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(97)00078-2     Document Type: Article

References (33)

1. 3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter. J Pharmacol Exp Ther 1995;273:435-44.
2. 123I]N-ω-fluoroalkyl-2β-carboxy-3β-(4-iodophenyl) nortropane esters in baboons. Nucl Med Biol 1995;22:211-9.
3. Bloomfield PM, Rajeswaran S, Spinks TJ, Hume SP, Myers R, Ashworth S, Clifford KM, Jones WF, Byars LG, Young J, Andreaco M, Williams CW, Lammertsma AA, Jones T. The design and physical characteristics of a small animal positron emission tomograph. Phys Med Biol 1995;40:1105-26.
4. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 1995;47:779-86.
5. Boja JW, McNeill RM, Lewin AH, Abraham P, Carroll FI, Kuhar MJ. Selective dopamine transporter inhibition by cocaine analogs. NeuroReport 1992;3:984-6.
6. 11C]RTI-121 - A potential radioligand for PET studies of the dopamine transporter. J Labelled Compd Radiopharm 1994;35:483-4.
7. 124I]RTI-121. J Labelled Compd Radiopharm. (in press).
8. 11C]WIN-35,428. J Labelled Compd Radiopharm 1993;30:147-52.
9. D'Mello GD, Goldberg DM, Goldberg SR, Stolerman IP. Conditioned taste aversion and operant behavior in rats: effects of cocaine, apomorphine and some long-acting derivatives. J Pharmacol Exp Ther 1981;219:60-8.
10. Farde L, Halldin C, Lundkvist C, Ginovart N, Hall H, Karlsson P, Swahn C, Neumeyer JL. Examination of [C-11]β-CIT-FP and [C-11]β-CIT-FE uptake in the human brain by PET. J Nucl Med 1996;37:284-285P.
11. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994;16:93-103.
12. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 1993;34:423-31.
13. 11C]CFT and PET in a primate model of parkinsonism. NeuroReport 1992;3:265-8.
14. Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, Fricker RA, Torres EM, Watson I, Jones T. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods 1996a;67:103-12.
15. 11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Nucl Med Biol 1996b;23:377-84.
16. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA. Quantitation of carbon-11 labelled raclopride in rat striatum using positron emission tomography. Synapse 1992;21:45-53.
17. Innis RB. Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease. Eur J Nucl Med 1994;21:1-5.
18. Izenwasser S, Rosenberger JG, Cox BM. The cocaine analog WIN 35 428 binds to two sites in fresh rat caudate-putamen: significance of assay procedures. Life Sci 1993;52:141-5.
19. Keen M, MacDermot J. Analysis of receptors by radioligand binding. In: Wharton J, Polak JM, editors. Receptor Autoradiography. Principles and Practice. Oxford, UK: Oxford University Press, 1993: 23-55.
20. Laihinen AO, Rinne JO, Någren KÅ, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Ruottinen HM, Rinne UK. PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson's disease. J Nucl Med 1995;36:1263-7.
21. 11C]raclopride studies. J Cereb Blood Flow Metab 1996a;16:42-52.
22. Lammertsma AA, Turjanski N, Hume SP, Luthra SK, Osman S, Piccini P, Brown DJ, Carroll FI, Brooks DJ. Quantification of dopamine transporter studies using carbon-11 labelled RTI-121 and PET. J Nucl Med 1996b;37:109P.
23. 123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993;13:295-309.
24. Laruelle M, Giddings SS, Zea-Ponce Y, Charney DS, Neumeyer JL, Baldwin RM, Innis RB. Methyl 3β-(4-[125]iodophenyl)tropane-2β-carboxylate in vitro binding to dopamine and serotonin transporters under 'physiological' conditions. J Neurochem 1994;62:978-86.
25. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1982;15:217-27.
26. Myers R, Hume SP, Ashworth S, Lammertsma AA, Bloomfield PM, Rajeswaran S, Jones T. Quantification of dopamine receptors and transporter in rat striatum using a small animal PET scanner. In: Myers R, Cunningham V, Bailey D, Jones T, editors. Quantification of Brain Function using PET. San Diego, USA: Academic Press, 1996: 12-15.
27. Opacka-Juffry J, Ashworth S, Hume SP, Martin D, Brooks DJ, Blunt SB. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. NeuroReport 1995;7:348-52.
28. Robb RA, Hanson DP. A software system for interactive and quantitative visualization of multidimensional biomedical images. Aust Phys Eng Med 1991;14:9-30.
29. 123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse 1992;11:134-9.
30. 3H]WIN 35,428. J Pharmacol Exp Ther 1991;257:954-8.
31. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn Schmiedebergs Arch Pharmacol 1985;329:227-35.
32. Volkow ND, Fowler JS, Logan J, Gatley SJ, Dewey SL, MacGregor RR, Schlyer DJ, Pappas N, King P, Wang G-J, Wolf AP. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study. J Nucl Med 1995;36:1289-97.
33. 18F-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. Nucl Med Biol 1996;23:141-6.